AMCS
12.5.2022 09:32:12 CEST | Business Wire | Press release
AMCS, a leading global supplier of integrated cloud-based software and vehicle technology for the environmental, utilities, waste, recycling, and resource industries, announced today that it has entered into an agreement to acquire Quentic, one of the leading solution providers of Software as a Service for EHSQ and ESG management, for an undisclosed amount. The transaction is subject to regulatory approval and is expected to close in the coming weeks.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220512005027/en/
In connection with AMCS’ acquisition of Quentic, Clearlake Capital Group, L.P. (together with its affiliates, “Clearlake”) is making a new equity investment in AMCS alongside new equity investments from existing investors Insight Partners, Ireland Strategic Investment Fund (ISIF), and Highland Europe.
AMCS continues strong growth globally
With this acquisition, AMCS will be positioned to broaden its expertise in the environmental services industry globally and continue to expand its customer base. With a combined 4,000 customers supported by over 1,000 employees, AMCS is on a trajectory to achieve run rate revenues greater than €180m by the end of the year.
AMCS extends environmental services offering across a wider industry
AMCS and Quentic are now positioned to provide more advanced digital solutions to a wider industry, which will enrich their customers’ operations and impact the environment for a healthier, cleaner, and more sustainable world.
Leveraging expertise to fuel a net zero carbon future
Combining forces is an important step for both companies as they leverage the expertise from each organization and jointly lead the way for added competence in the market. Managing resources from cradle-to-cradle has become a key responsibility for businesses across all industries. The integration of AMCS and Quentic enables customers on both sides to benefit from a wide range of solutions that support end-to-end standardization and optimization of business processes to increase efficiencies, streamline operations and work toward a safe and sustainable future.
“AMCS and Quentic are very aligned with the mission to drive an environmentally sustainable future”, says Jimmy Martin, CEO of AMCS. “A net zero carbon future depends on a very connected and circular approach across the supply chain. We are thrilled to bring the technology from Quentic into the AMCS portfolio of solutions and can now move forward with a focus on influencing the entire supply chain, offering smarter outcomes from automating and digitizing their businesses -- reducing waste as much as possible.”
Quentic adds 15 years of EHSQ excellence to AMCS’ portfolio
CEO Markus Becker, COO Sebastian Mönnich and CTO Hardy Menzel founded Quentic, formerly EcoIntense, in 2007 to provide software for environmental management. Today, Quentic provides a holistic and modular Software as a Service solution to manage all tasks and processes related to environmental, health, safety, and quality management (EHSQ) as well as corporate responsibility-related areas in environment, social and governance (ESG).
“We have built Quentic on the values of making a meaningful contribution to people, society and the environment”, Markus Becker, CEO of Quentic said. “Therefore, we are excited to have found a partner in AMCS who fully aligns with our mission to digitally empower companies across the globe to manage people, business and environmental processes sustainably at all levels. Together with AMCS, the Quentic management team will continue to shape the future.”
About AMCS
AMCS is headquartered in Limerick, Ireland with offices in North America, Europe, and Australia employing over 800 people across 12 countries. AMCS is a global leader of integrated software and vehicle technology for the environmental, recycling, and resource industries and offers optimization solutions to the broader transport and logistics market. AMCS helps over 3,000 customers in 22 countries to reduce their operating costs, increase asset utilization, optimize margins, and improve customer service. Their enterprise software and SaaS solutions deliver digital innovation to the emerging circular economy around the world.
About Quentic
Quentic is one of the leading solution providers of Software as a Service (SaaS) for EHSQ and ESG management. The Quentic platform comprises ten individually combinable modules and offers an ideal way for companies to manage Health & Safety, Risks & Audits, Incidents & Observations, Hazardous Chemicals, Control of Work, Legal Compliance, Online Instructions, Processes, Environmental Management and Sustainability.
The company is headquartered in Berlin, Germany, and employs more than 250 people. Branch offices are located in Germany, Austria, Switzerland, Finland, Sweden, Denmark, Belgium, the Netherlands, France, Spain and Italy.
About Clearlake Capital Group, L.P.
Clearlake Capital Group, L.P. is an investment firm founded in 2006 operating integrated businesses across private equity, credit, and other related strategies. With a sector-focused approach, the firm seeks to partner with management teams by providing patient, long-term capital to businesses that can benefit from Clearlake’s operational improvement approach, O.P.S.® The firm’s core target sectors are technology, industrials, and consumer. Clearlake currently has over $72 billion of assets under management, and its senior investment principals have led or co-led over 400 investments. The firm is headquartered in Santa Monica, CA with affiliates in Dallas, TX, London, UK and Dublin, Ireland. More information is available at www.clearlake.com and on Twitter @Clearlake.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220512005027/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
